NAVIGATOR aims to create tools to study hereditary diseases linked to CTNNA1 deficiency, including cancer and other health problems. We want to improve the diagnosis of these conditions and the treatment of associated cancers. We will do this by bringing together experts, collaborating internationally and applying the results quickly to patients. We will also share our findings through relevant publications and other means.